Loading
A phase 2 trial of adebrelimab in lung cancer, run by Sichuan University, now recruiting.
Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC) is a phase 2, randomised interventional study registered as NCT06610734 by Sichuan University, with a registry enrolment figure of 202 participants, started 2024-12-23 and due to reach its primary completion in 2026-12. Interventions recorded: Adebrelimab; Chemotherapy; low dose radiotherapy. Conditions listed: Small Cell Lung Cancer Extensive Stage. Primary outcome: overall survival. Lung eligibility wording from the registry: "* Histologically or cytologically confirmed extensive small cell lung cancer (according to the VALG staging system);". Sites: China. No results are recorded here; the registry entry is the source.
Shares Adebrelimab, Extensive-stage small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Extensive-stage small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Adebrelimab, Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag lung-deep-dive.
Shares Adebrelimab, Extensive-stage small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Adebrelimab, Extensive-stage small-cell lung cancer, Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag lung-deep-dive.
Shares Adebrelimab, Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag lung-deep-dive.
Shares Adebrelimab, Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag lung-deep-dive.
Shares Extensive-stage small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.